Treatment of HIV infection with once-daily regimens

Author： Permpalung Nitipong   Putcharoen Opass   Avihingsanon Anchalee   Ruxrungtham Kiat  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.16, 2012-11, pp. : 2301-2317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Once-Daily Regimens in the Treatment of HIV Infection

By Molina Jean-Michel  

Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. : 567-578

Adis International

Access to resources Recommend Favorite

Elvitegravir: a once-daily inhibitor of HIV-1 integrase

By Wills Todd   Vega Vivian  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 395-401

Informa Healthcare

Access to resources Recommend Favorite

Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS

By Mateo Ma Gracia   Gutierrez Ma del Mar   Vidal Francesc   Domingo Pere  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1055-1064

Informa Healthcare

Access to resources Recommend Favorite

Once daily lamivudine looks promising in HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Triple therapy including once-daily emtricitabine effective in HIV

By  

Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite